Download
s13148-021-01052-2.pdf 1,95MB
WeightNameValue
1000 Titel
  • Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients
1000 Autor/in
  1. Stomper, Julia |
  2. Meier, Ruth |
  3. Ma, Tobias |
  4. Pfeifer, Dietmar |
  5. Ihorst, Gabriele |
  6. Blagitko-Dorfs, Nadja |
  7. Greve, Gabriele |
  8. Zimmer, Dennis |
  9. Platzbecker, Uwe |
  10. Hagemeijer, Anne |
  11. Schmitt-Graeff, Ingrid |
  12. Lübbert, Michael |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-04-12
1000 Erschienen in
1000 Quellenangabe
  • 13(1):77
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13148-021-01052-2 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043064/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Mutations in the EZH2 gene are recurrently found in patients with myeloid neoplasms and are associated with a poor prognosis. We aimed to characterize genetic and epigenetic alterations of EZH2 in 58 patients (51 with acute myeloid leukemia and 7 with myelodysplastic or myeloproliferative neoplasms) by integrating data on EZH2 mutational status, co-occurring mutations, and EZH2 copy number status with EZH2 protein expression, histone H3K27 trimethylation, and EZH2 promoter methylation.!##!Results!#!EZH2 was mutated in 6/51 acute myeloid leukemia patients (12%) and 7/7 patients with other myeloid neoplasms. EZH2 mutations were not overrepresented in patients with chromosome 7q deletions or losses. In acute myeloid leukemia patients, EZH2 mutations frequently co-occurred with CEBPA (67%), ASXL1 (50%), TET2 and RAD21 mutations (33% each). In EZH2-mutated patients with myelodysplastic or myeloproliferative neoplasms, the most common co-mutations were in ASXL1 (100%), NRAS, RUNX1, and STAG2 (29% each). EZH2 mutations were associated with a significant decrease in EZH2 expression (p = 0.0002), which was similar in patients with chromosome 7 aberrations and patients with intact chromosome 7. An association between EZH2 protein expression and H3K27 trimethylation was observed in EZH2-unmutated patients (R!##!Conclusions!#!Perturbations of EZH2 activity in AML/MDS occur on different, genetic and non-genetic levels. Both low EZH2 protein expression and, by trend, EZH2 gene mutations predicted inferior overall survival of AML patients receiving standard chemotherapy.
1000 Sacherschließung
lokal Aged, 80 and over [MeSH]
lokal Aged [MeSH]
lokal DNA Copy Number Variations/genetics [MeSH]
lokal EZH2
lokal Histones/genetics [MeSH]
lokal Protein expression
lokal H3K27 trimethylation
lokal Mutations
lokal Myelodysplastic Syndromes/genetics [MeSH]
lokal Cohort Studies [MeSH]
lokal Gene Expression/genetics [MeSH]
lokal Acute myeloid leukemia
lokal Survival
lokal Male [MeSH]
lokal Promoter methylation
lokal Leukemia, Myeloid, Acute/genetics [MeSH]
lokal Mutation/genetics [MeSH]
lokal Female [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Enhancer of Zeste Homolog 2 Protein/genetics [MeSH]
lokal Middle Aged [MeSH]
lokal Cancer epigenetics and diagnostics
lokal Research
lokal Prognosis [MeSH]
lokal Young Adult [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U3RvbXBlciwgSnVsaWE=|https://frl.publisso.de/adhoc/uri/TWVpZXIsIFJ1dGg=|https://frl.publisso.de/adhoc/uri/TWEsIFRvYmlhcw==|https://frl.publisso.de/adhoc/uri/UGZlaWZlciwgRGlldG1hcg==|https://frl.publisso.de/adhoc/uri/SWhvcnN0LCBHYWJyaWVsZQ==|https://frl.publisso.de/adhoc/uri/QmxhZ2l0a28tRG9yZnMsIE5hZGph|https://frl.publisso.de/adhoc/uri/R3JldmUsIEdhYnJpZWxl|https://frl.publisso.de/adhoc/uri/WmltbWVyLCBEZW5uaXM=|https://frl.publisso.de/adhoc/uri/UGxhdHpiZWNrZXIsIFV3ZQ==|https://frl.publisso.de/adhoc/uri/SGFnZW1laWplciwgQW5uZQ==|https://frl.publisso.de/adhoc/uri/U2NobWl0dC1HcmFlZmYsIEluZ3JpZA==|https://orcid.org/0000-0003-1186-1650
1000 Hinweis
  • DeepGreen-ID: 2ab38d3c0e75490aa3f86016d620f93d ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6463995.rdf
1000 Erstellt am 2023-11-15T23:24:28.985+0100
1000 Erstellt von 322
1000 beschreibt frl:6463995
1000 Zuletzt bearbeitet Thu Nov 30 22:47:14 CET 2023
1000 Objekt bearb. Thu Nov 30 22:47:14 CET 2023
1000 Vgl. frl:6463995
1000 Oai Id
  1. oai:frl.publisso.de:frl:6463995 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source